Anti-cGAS antibody
5
(2 Reviews)
|
(17 Publications)
Rabbit Polyclonal CGAS antibody. Suitable for WB and reacts with Human samples. Cited in 17 publications. Immunogen corresponding to Recombinant Fragment Protein within Human CGAS aa 300 to C-terminus.
View Alternative Names
C6orf150, MB21D1, CGAS, Cyclic GMP-AMP synthase, cGAMP synthase, cGAS, h-cGAS, 2'3'-cGAMP synthase, Mab-21 domain-containing protein 1
- WB
Supplier Data
Western blot - Anti-cGAS antibody (AB224144)
All lanes:
Western blot - Anti-cGAS antibody (ab224144)
Lane 1:
CACO-2 cell lysate
Lane 2:
HEK293 cell lysate
Predicted band size: 59 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CGAS plays a fundamental role in the immune response by activating the STING pathway. cGAS when bound to DNA forms a complex with DNA as part of its mechanistic function which then catalyzes the synthesis of cGAMP. The cGAMP produced acts as a signaling molecule that activates the STING protein leading to subsequent immune signaling cascades. This activation results in the production of type I interferons and other inflammatory cytokines essential for mounting an effective antiviral response.
Pathways
CGAS operates within important signaling pathways such as the cGAS-STING pathway and the type I interferon pathway. This protein works closely with STING located on the endoplasmic reticulum as a direct effector. The connection between cGAS and STING is important in detecting and responding to cytosolic DNA and initiating immune signaling leading to activation of downstream transcription factors like IRF3 and NF-kB which promote gene expression driving immune responses.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (17)
Recent publications for all applications. Explore the full list and refine your search
Frontiers in immunology 16:1592737 PubMed40799648
2025
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 43:3587-3603 PubMed38951609
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal for immunotherapy of cancer 12: PubMed38749537
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology, immunotherapy : CII 73:92 PubMed38564022
2024
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 129:1852-1862 PubMed37838813
2023
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 30:200-213 PubMed37663305
2023
Applications
Unspecified application
Species
Unspecified reactive species
International journal of radiation oncology, biology, physics 117:955-965 PubMed37244631
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell death discovery 9:136 PubMed37100799
2023
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 42:e111961 PubMed36574362
2022
Applications
Unspecified application
Species
Unspecified reactive species
Vaccines 10: PubMed36560581
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com